Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul 13;16(7):1674-1685.
doi: 10.1016/j.stemcr.2021.05.010. Epub 2021 Jun 10.

From development toward therapeutics, a collaborative effort on blood progenitors

Avik Choudhuri  1 , Tianxiao Han  1 , Leonard I Zon  2
Affiliations

From development toward therapeutics, a collaborative effort on blood progenitors

Avik Choudhuri et al. Stem Cell Reports. .

Abstract

The National Heart, Lung, and Blood Institute Progenitor Cell Translational Consortium Blood Progenitor Meeting was hosted virtually on November 5, 2020, with 93 attendees across 20 research groups. The purpose of this meeting was to exchange recent findings, discuss current efforts, and identify prospective opportunities in the field of hematopoietic stem and progenitor cell research and therapeutic discovery.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest L.I.Z. is a founder and stockholder of Fate Therapeutics, CAMP4 Therapeutics, Amagma Therapeutics, and Scholar Rock. He is a consultant for Celularity and Cellarity outside the submitted work. All other authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Schematic summarization of the ongoing research regarding different biological systems to benefit HSC-based cellular regenerative therapies presented at the meeting
See this image and copyright information in PMC

References

    1. Advani R., Flinn I., Popplewell L., Forero A., Bartlett N.L., Ghosh N., Kline J., Roschewski M., LaCasce A., Collins G.P. CD47 blockade by Hu5F9-G4 and rituximab in non-Hodgkin’s lymphoma. N. Engl. J. Med. 2018;379:1711–1721. - PMC - PubMed
    1. An H.H., Poncz M., Chou S.T. Induced pluripotent stem cell-derived red blood cells, megakaryocytes, and platelets: progress and challenges. Curr. Stem Cell Rep. 2018;4:310–317.
    1. Bachanova V., Miller J.S. NK cells in therapy of cancer. Crit. Rev. Oncog. 2014;19:133–141. - PMC - PubMed
    1. Badwe C.R., Lis R., Barcia Duran J.G., Kunar B., Rafii S. Fli1 is essential for the maintenance of hematopoietic stem cell homeostasis and function. Blood. 2017;130:3769.
    1. Barbier V., Erbani J., Fiveash C., Davies J.M., Tay J., Tallack M.R., Lowe J., Magnani J.L., Pattabiraman D.R., Perkins A.C. Endothelial E-selectin inhibition improves acute myeloid leukaemia therapy by disrupting vascular niche-mediated chemoresistance. Nat. Commun. 2020;11:2042. - PMC - PubMed

Publication types